NewswireToday - /newswire/ -
Greenville, NC, United States, 2011/11/07 - Metrics was singled out from among 400 CMOs worldwide for outstanding performance in four categories – quality, reliability, accessibility and regulatory - Metricsinc.com / Sinclair-Co.com.
Metrics, Inc. has received a CMO Leadership Award recognizing the company’s outstanding performance in solid-dose contract manufacturing service.
The CMO Leadership Award is presented by Life Science Leader magazine based on pharmaceutical industry research conducted by Nice Insight.
Nice Insight surveyed corporate users of contract pharmaceutical manufacturing organizations (CMOs) to find out which companies stood apart in several different categories. Metrics was singled out from among 400 CMOs worldwide for outstanding performance in four categories – quality, reliability, accessibility and regulatory.
“Quality, reliability, accessibility, regulatory expertise – these are the same core values on which we founded Metrics, so it is extremely satisfying to know that our customers expressed confidence in these particular strengths,” said Phil Hodges, president and CEO. “As always, our employees deserve appreciation for this award because they provide excellent service every day.”
Metrics Inc. is one of the most respected contract pharmaceutical development and manufacturing companies in the United States today.
Started as an analytical laboratory in 1994, Metrics has evolved into a full-service provider of quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical material manufacturing (CTM) for Phase I, II and III trials; commercial manufacturing; and analytical method development and validation services.
Headquartered in Greenville, N.C., Metrics (metricsinc.com) has particular expertise in FTIM and Phase I, II, and III CTM manufacturing. The company has conducted more than 120 FTIM projects for different chemical entities in the last five years alone – while developing more than 700 batches of CTM in the same period.